[S,S]-Reboxetine add-on trial: a randomized, double-blind, placebo-controlled, multi-center trial of [S,S]-reboxetine in patients with postherpetic neuralgia (PHN) concomitantly treated with pregabalin

Trial Profile

[S,S]-Reboxetine add-on trial: a randomized, double-blind, placebo-controlled, multi-center trial of [S,S]-reboxetine in patients with postherpetic neuralgia (PHN) concomitantly treated with pregabalin

Discontinued
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2016

At a glance

  • Drugs Esreboxetine; Pregabalin
  • Indications Postherpetic neuralgia
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 15 Jul 2008 Status changed from recruiting to discontinued, due to insufficient clinical response, according to clinicaltrials.gov record.
    • 01 Feb 2007 New trial locations added
    • 15 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top